Doxorubicin-loaded albumin nanoparticles: Formulation and characterization

Journal of Nanoscience and Nanotechnology

Volumn 10, Issue 11, 2010, Pages 7752-7757

  Honary, S ^a   Jahanshahi, M ^b   Golbayani, R ^b   Ebrahimi, R ^c   Ghajar, K ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF MAZANDARAN   (Iran)

^c Gonbad Institutes of Higher Education   (Iran)

Author keywords

Doxorubicin hydrochloride; Drug delivery; Drug release; DSC; Nanomedicine; SEM

Indexed keywords

DOXORUBICIN HYDROCHLORIDE; DRUG RELEASE; DSC; NANOMEDICINES; SEM;

BODY FLUIDS; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY; DYNAMIC LIGHT SCATTERING; ELECTROPHORESIS; MEDICAL NANOTECHNOLOGY; SCANNING ELECTRON MICROSCOPY;

NANOPARTICLES;

ALBUMINOID; DOXORUBICIN; NANOPARTICLE;

ARTICLE; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SCANNING ELECTRON MICROSCOPY; THIN LAYER CHROMATOGRAPHY;

ALBUMINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; DOXORUBICIN; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES;

EID: 79952113803     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2010.2832     Document Type: Conference Paper

References (21)

1. S. Gelperina, K. Kisich, M. D. Iseman, and L. Heifets, J. Respiratory and Critical Care Medicine, 172, 1487 (2005).
2. P. Couvreur, L. Roblot-Treupel, M. F. Poupon, F. Brasseur, and F. Puisieux, Adv. Drug Delivery Review 5, 209 (1990).
3. L. Brannon-Peppas and I. O. Blanchette, Adv. Drug Delivery Review 56, 1649 (2004).
4. L. S. Jabr-Milane, L. E. Vierken, S. Yadav, and M. M. Amiji, Cancer Treatment Review 34, 592 (2008).
5. S. Honary, P. Ebrahimi, M. Tabbakhian, and F Zahir, Formulation and characterization of doxorubicin nanovesicles.
6. N. Tang, G. Du, N. Wang, Ch. Liu, H. Hang, and W. Liang, J. Natl Cancer Inst. 27, 1004 (2007).
7. M. Kumar, J. Pharm. Pharmaceut Sci. 3, 234 (2000).
8. A. Mabmud, X. B. Xiong, and A. Lavasanifar, J. Pharm. Biopharm. 69, 923 (2008).
9. M. Gaumet, A. Vargas, R. Gurny, and F. Delie, J. Pharm. Biopharm. 69, 1 (2008).
10. H. Maeda, G. Y. Bharate, I. Daruwalla, J. Pharm. Biopharm. 71, 409 (2009).
11. F. Kratz, J. Controlled Release 132, 171 (2008).
12. R. Arshady, J. Controlled Release 14, 111(1990).
13. A. K.Zimmer, H. Zerbe, and I. Kreuter, J. Controlled Release 32, 57 (1994).
14. A. K. Zimmer, Ph. Maincent, P. Thouvenot, and I. Kreuter, J. Pharmaceutics 3, 211(1994).
15. R. Pignatello, C. Bucolo, P. Ferrara, A. Maltese, A. Puleo, and G. Puglisi, J. Pharmaceutical Sci. 16, 53 (2002).
16. R. Pignatello, C. Bucolo, G. Spedalieri, A. Maltese, and G. Puglisi, J. Biomaterials 23, 3247 (2002).
17. W. Lin, M. C. Garnett, S. S. Davis, E. Schacht, P. Ferruti, and L. Illum, J. Controlled Release 71, 117 (2001).
18. M. Merodio, A. Arnedo, M. I. Renedo, and I. M. Irache, J. Pharmaceutical Sci. 12, 251 (2001).
19. S. Dreis, F. Rothweiler, M. Michaelis, I. Cinatl, Jr, I. Kreuter, and K. Langer, Int. J. Pharm. 341, 207 (2007).
20. E. Leo, M. A. Vandelli, R. Cameroni, and F Forni, Int. J. Pharm. 155, 75 (1997).
21. I. Oh, K. Lee, H. Kwon, Y. Lee, S. Shin, Ch. Cho, and Ch. Kim, Int. J. Pharm. 181, 107 (1999).